The Economic Substance legislation was introduced by the Crown Dependencies and Overseas Territories on 1 January 2019. This prompted resident “in scope” companies to examine their day-to-day activities and governance in relevant jurisdictions, with an emphasis on ensuring compliance with the new regulations and further enhancing well-ingrained business practices.
Broadly speaking, economic substance requirements will be met if an “in scope” entity can demonstrate:
Below, we’ve re-visited each of the requirements, summarising the details and reflecting on our observations from 18 months working in line with the regulations.
The new rules prompted a review of board compositions, leading us to also review the physical presence of boards for board meetings, ensuring this first requirement could be met. We have found that many client boards required no changes, as firstly, non-local directors would travel to the relevant jurisdiction for board meetings and, secondly, boards were made up of locally appointed, highly experienced non-executive directors (NEDs) and / or directors from local service providers.
Where changes have been viewed as necessary, some of the steps taken have included:
It is worth adding that there is some flexibility to allow for urgent strategic decisions to be made without a board majority in the relevant jurisdiction, for example where face to face negotiations might be vital to a successful outcome.
I will look at each of these areas separately but, firstly, by way of a reminder: the term “adequate” has not been defined in the substance requirements. We therefore refer to the dictionary definition, which tells us “adequate” means “enough or satisfactory for a particular purpose”. When using this definition in the context of the substance rules, it really comes down to the board considering the relevant activities that the entity undertakes and taking a view. It is also worth noting that there were already stringent regulatory requirements covering entities undertaking a number of the relevant activities, which meant an overlap with the substance requirements.
Let’s now move to an overview of the three specific areas that need to be met:
Certainly, where there is an appointed service provider, we have not seen any potential issues with meeting these three requirements. Noting the age of the industry in our relevant jurisdictions, this means there are suitably experienced NEDs / directors sitting on the boards, service providers have adequate premises and experienced employees, and existing regulatory requirements are being adhered to – all of which can give boards comfort that certain aspects can be deemed “adequate”.
For each of the relevant activities, the types of CIGA are explained in detail in the legislation and supporting guidance notes. It is important to remember that an entity can be conducting more than one relevant activity, so CIGA for all must be considered.
To ensure that CIGA is conducted in relevant jurisdictions, we have seen increased planning around which board decisions need to be made during a fund’s lifetime, and whether those decisions should be categorised as CIGA decisions.
Clearly, the legislation never intended to impact the successful outcome of investments and, as noted above, there is flexibility to have some CIGA decisions taken out of the jurisdiction. With this in mind, we have been supporting client boards with the planning and scoping out of the types of decisions taken during the life of fund. We have then been able to determine the best framework to make these decisions in respect of the board composition.
Our role as an administrator has also seen us supporting with the enhancement of entities’ governance frameworks. This has involved existing minute logs being rebranded as substance registers, in order to capture all the information required for easy extraction and for inclusion in the annual tax return.
To bring the regulations to life, we have detailed a of scenarios worked on during the last 18 months:
Entity details prior to substance rules
The board was made up of one Jersey-based NED, one Jersey service provider appointed director, one UK director and one EU-based director. Meetings were always held in Jersey, with all directors only attending quarterly meetings in person, to consider the fund reports and any investment decisions at that time. Other meetings held, including those for investment decisions, were typically telephone meetings.
Post Substance legislation
Changes have been made. A new Jersey NED was added to the board and suitably qualified Jersey alternates were appointed by the UK and EU directors. This has ensured a majority can be present in the resident jurisdiction.
Monitoring prior to substance rules
Various information related to each board meeting held was maintained in a minute log, essentially to track dates of meetings, directors in attendance, a summary of agenda items and sometimes to include matters arising and a summary of related actions.
Post Substance legislation
In view of the requirement to track a lot more information for inclusion in an “in scope” entity’s tax return, the minute log was adapted to become a “substance register” to also track when and where CIGA decisions were considered, the physical location of each director in attendance, duration of the meeting and confirmation of qualification to ensure the board are suitably qualified in relation to the relevant activity. This allows for the easy extraction of the required information without any burdensome additional steps to existing processes.
Of course, the coronavirus pandemic has created a level of disruption that no-one could have imagined just a few months ago. Fortunately, regulators have responded to this crisis with a reassuring amount of practical flexibility. Back in March, Guernsey and Jersey communicated that they would be taking a “pragmatic approach” in applying economic substance regulation for the foreseeable future, including the announcement that board meetings would not have to be attended in person, and could be attended via conference call or video conferencing. The relaxation of regulations extends to location only as there is still the expectation for companies to conduct the rest of their affairs in line with existing procedures still exists.
Overall, it is encouraging to see regulators evolve existing rules to suit changing circumstances, while helping to ensure boards can continue to function. However, we do expect the relaxation of the application of economic substance rules to be temporary.
With all the analysis completed and changes to the board composition and governance framework fully effected, boards of “in scope” entities are operating smoothly. Our focus is now on the extrapolation of the relevant data in order to be added to the tax returns, as these returns have seen a significant amount of change for “in scope” entities. This being the first year of returns for substance-impacted entities, careful attention is being paid to the process, ensuring utmost accuracy and no double counting. However, with all the data readily available and the latest technology at our fingertips, we do not envisage any issues.
We may also see new guidance issued over time and therefore we continue to have ongoing dialogue with ‘Big Four’ accountancy firms, and the industry in general.
The introduction of this legislation has not caused any serious concerns, as the intention of the substance requirements was to codify existing good practice. With careful planning and attention to detail, we have been able to make minor changes to board compositions and update relevant entities’ existing governance frameworks. Now it is back to business as usual.
Ultimately, the regulations have had a positive effect. Substance requirements have only helped to reinforce strong corporate governance already in place, further enhancing the reputation of the relevant jurisdictions in which we operate.
To discover for yourself what makes us the bright alternative and how we can support, please contact Reshentha Beeby, our Director.